CN107287270A - A kind of tower draws oligopeptide and its industrialized process for preparing and purposes - Google Patents
A kind of tower draws oligopeptide and its industrialized process for preparing and purposes Download PDFInfo
- Publication number
- CN107287270A CN107287270A CN201710588063.7A CN201710588063A CN107287270A CN 107287270 A CN107287270 A CN 107287270A CN 201710588063 A CN201710588063 A CN 201710588063A CN 107287270 A CN107287270 A CN 107287270A
- Authority
- CN
- China
- Prior art keywords
- tower
- food
- oligopeptide
- enzyme activity
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010038807 Oligopeptides Proteins 0.000 title claims abstract description 24
- 102000015636 Oligopeptides Human genes 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 27
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims abstract description 18
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 15
- 230000036541 health Effects 0.000 claims abstract description 6
- 238000009826 distribution Methods 0.000 claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 28
- 229940088598 enzyme Drugs 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 26
- 235000017399 Caesalpinia tinctoria Nutrition 0.000 claims description 19
- 241000388430 Tara Species 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- 239000000706 filtrate Substances 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 150000003254 radicals Chemical class 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000004365 Protease Substances 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 239000012466 permeate Substances 0.000 claims description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 6
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 101710130006 Beta-glucanase Proteins 0.000 claims description 5
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- 230000015556 catabolic process Effects 0.000 claims description 4
- 238000006731 degradation reaction Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 230000002779 inactivation Effects 0.000 claims description 4
- 210000002540 macrophage Anatomy 0.000 claims description 4
- 238000001471 micro-filtration Methods 0.000 claims description 4
- 238000001728 nano-filtration Methods 0.000 claims description 4
- 235000019419 proteases Nutrition 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- -1 Casing piece Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 2
- 108010004032 Bromelains Proteins 0.000 claims description 2
- 108010019160 Pancreatin Proteins 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 102000057297 Pepsin A Human genes 0.000 claims description 2
- 108090000284 Pepsin A Proteins 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 2
- 235000019835 bromelain Nutrition 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 230000007681 cardiovascular toxicity Effects 0.000 claims description 2
- 231100000060 cardiovascular toxicity Toxicity 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 230000000242 pagocytic effect Effects 0.000 claims description 2
- 229940055695 pancreatin Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 229940111202 pepsin Drugs 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 230000003248 secreting effect Effects 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 108010001682 Dextranase Proteins 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 230000006837 decompression Effects 0.000 claims 1
- 239000013618 particulate matter Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 230000002000 scavenging effect Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 35
- 239000002956 ash Substances 0.000 description 33
- 239000012153 distilled water Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 235000013312 flour Nutrition 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 235000002918 Fraxinus excelsior Nutrition 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000007760 free radical scavenging Effects 0.000 description 4
- 235000007627 Caesalpinia Nutrition 0.000 description 3
- 241000522234 Caesalpinia Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000008274 jelly Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 235000015099 wheat brans Nutrition 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000014220 Rhus chinensis Nutrition 0.000 description 2
- 240000003152 Rhus chinensis Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012490 blank solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Oligopeptide and its industrialized process for preparing and purposes are drawn the present invention relates to a kind of tower.The peptide content of the oligomeric Gly-His-Lys accounts for more than 98% in more than 80wt%, molecular weight distribution in below 1500Dalton, and ash content is not higher than 5%.The method of the present invention is easy to operate, inexpensive in high yield, and product quality is stable, technique environmental protection, is adapted to large-scale production.The tower, which drags down poly- Gly-His-Lys, has preferable radicals scavenging effect, therefore can prepare the medicine, food or health products for treating relevant disease.
Description
Technical field
The present invention provides a kind of tower and draws oligopeptide and its industrialized producing technology and application thereof, belongs to food deep processing neck
Domain.
Background technology
Tower draws (Caesalpinia spinose Kuntze) also known as Caesalpinia spinosaKuntze (Tara), is Caesalpiniaceae Caesalpinia,
The main main country such as the Peru of the northwestward, Ecuador, Colombia in South America of distribution, abounds with Peru.Its dry heat resistance,
Fast-growing, evergreen, perpetual bloom, are one of fine tree species of planting trees on barren hills.Its long lifespan abounds with the phase about 20 years up to more than 50 years,
3-4 per mu yields beanpod is up to more than 300 kilograms after cultivation.It is that worker employed in a plant nursery is few, invests small, income is big, the excellent economic forest tree of many benefits of a labor
Kind.The beginning of the nineties in last century, Resources Insect Inst., Chinese Academy of Forestry Sciences has introduced the production of replacement Chinese gall from South America
Supplement material plant-the Ta La of nutgall tannin and its series of products, and plant into Yunnan Province is xeothermic, dry-warm valley is regional
Work(.To 2006, Yunnan was developed tower and furthered 1.5 ten thousand mu, and the provinces and regions such as Guizhou, Sichuan, Guangxi and Hainan also begin to introduce a fine variety.Tower is drawn
Beanpod 55-61% containing talas of tannic acid, can produce hundreds of medicine and chemical products;Its benevolence glucomannoglycan containing gala is about
34%, the tara gum for having important use in terms of food, medicine, weaving, papermaking and oil drilling can be produced, while in benevolence
Contain 13% aliphatic acid (linoleic acid accounts for the 52-54% of total fatty acids).Researcher is extracted stigmasterol and paddy steroid from Tara seeds
(two alcohol account for the 90% of sterol total amount to alcohol, and the former is the primary raw material for producing cloud big 120, and the latter can produce hypolipidemic, are worth
Up to more than 1000 dollars/kilogram).The beans purposes is wide, and nontoxic edible, is a kind of precious woody beans.Show Tara seeds according to the study
In containing more than 13% protein, be a kind of important vegetable protein sources.Compared with albumen, its hydrolysate tower drags down poly-
In addition to the characteristics of peptide has high-quality protein as amino acid constitutes and draws albumen with tower, also drawn with tower not available for albumen
The physicochemical property such as good dissolubility, stability, and with easily absorb and low-allergen, reduction blood fat and
Cholesterol, reduce blood pressure, promote the different physiological roles such as mineral absorption and fat metabolism, enhancing athlete's physique, therefore opening
Fa Tala oligopeptides have become the study hotspot in food and medicine field.Our A of early stage patent CN 105925648 disclose tower
The preparation technology of albumen and its peptide is drawn, peptide content is not less than 70wt%, and more than 95% peptide molecular weight is less than 1500Dalton, ash
Divide 10% or so.Oligopeptide is drawn in order to obtain the tower that peptide content is higher and ash content is lower, and applied to industrial production, this hair
Bright to draw oligopeptide preparation technology there is provided a kind of more excellent tower, the tower obtained by preparation draws the peptide content of oligopeptide more than 80%,
Ash content is controlled below 5%.Meanwhile, biologos experiment shows, the tower of this technique productions, which drags down poly- Gly-His-Lys, equally to be had more preferably
Antioxidation activity, the medicine, food or health products for excessively causing relevant disease for treating free radical can be prepared.
In food in addition to containing large amount of organic matter, also containing more rich inorganic constituents.These inorganic constituents are maintained
The normal physiological function of human body, has highly important effect in terms of constituting tissue.Food is remained after high temperature sintering
Inorganic substances be referred to as ash content.Ash content is mainly the mineral salt or inorganic salts in food, and it is to evaluate food to determine ash content in food
One of index of quality.For food service industry, ash content is the important quality index of a body.For example, adding in flour
In work, flour grade is often evaluated with total ash content, because 20 times higher than endosperm or so of the content of ashes of wheat bran, because
This, the machining accuracy of flour is higher, and content of ashes is lower.When producing the gelled products such as pectin, gelatin, this can be explained in total ash
The jelly performance of a little products;Water-soluble ass then largely shows the fruit content in the fruit products such as jam, jelly;
And the increase of acid-insoluble ash then imply that pollution and adulterate.This is to ensureing that food quality is highly important.Food and medicine
The control of ash content has following significances in product:
(1) total ash content of food is the important evidence for controlling food products or semi-manufactured goods quality.Such as:In milk
Content of the total ash in milk is constant.Typically in 0.68%--0.74%, average value closely 0.70%, therefore can
It is whether adulterated to determine milk with the method for determining total ash in milk, if water mixing, ash content reduction.It can in addition contain judge concentration
Than if measuring milk ash content 1.4% or so, illustrating that milk concentrates one times.Wheat bran content of ashes in and for example superior wheat flour, wheat
Height, and protein content is high in endosperm, the content of the ash rate endosperm of wheat bran is high 20 times, that is the precision in flour is high, then
Ash content is just low.
(2) whether evaluation food is hygienic, either with or without pollution.Different food, because of raw materials used, processing method and measure bar
The difference of part, the composition and content of various ash contents are also differed, after these conditions are determined, the ash content of certain food is often certain
In the range of.If content of ashes has exceeded normal range (NR), illustrate to have used the original departing from sanitary standard requirement in food production
Material or food additives, or food are contaminated in processing, transporting procedures.Therefore, determine ash content may determine that food by
The degree of pollution
(3) judge whether food is adulterated.
(4) reference index (can be by surveying various elements) of nutrition is evaluated.
(5) machining accuracy and food quality of food can be judged.Inorganic salts are one of six big nutritional factors, are mankind's lifes
The indispensable material of life activity, will correctly evaluate certain nutritive value of food, and its inorganic salt content is an evaluation index.Example
As usual to evaluate flour grade with total ash content, superior wheat flour is 0.3-0.5%;Standard flour is 0.6-0.9%.Produce pectin, bright
During the colloid product of glue etc, ash content is the mark of the jelly performance of these products.
The content of the invention
Oligopeptide and its industrial preparation process are drawn the invention discloses a kind of tower, it is intended to ensure the premise of product yield
Under there is provided the industrial preparation process that a kind of peptide content is higher and ash content is lower tower draws oligopeptide, technique is more easy, green
Environmental protection, is adapted to large-scale production.The tower of this technique productions, which drags down poly- Gly-His-Lys, has more preferable antioxidation activity, can be used for treatment
Or medicine, food or the health food of the excessive caused symptom of prevention free radical.
In the preparation process that tower draws oligopeptide, due in protein extraction and enzymolysis process, to reach biological enzyme reaction
Condition, constantly adds hydrochloric acid and sodium hydroxide, causes the content of salt high, so as to cause content of ashes high.Higher ash content, shadow
Peptide content in product is rung.Because the molecular weight of salt is smaller, the purification process of early stage peptide is all the milipore filter of larger molecular weight, most
The permeate for milipore filter collected afterwards, therefore peptide, amino acid and salt are in permeate, it is impossible to salt is removed.
The ash content of numerous food is controlled in 8wt%, national standard (the GBT 22492- of such as soy peptide powder in the prior art
2008, its content is fully incorporated and referred to herein).But using the application preparation method, ash content can be controlled in 5wt% with
Under.
To reach above-mentioned purpose, the technical solution adopted by the present invention is:
A kind of tower draws oligopeptide, it is characterised in that:Using GB/T 22492-2008 appendix As and the detection method of Appendix B,
Peptide content is measured in more than 80wt%, molecular weight accounts for more than 98% less than below 1500Dalton, and its molecular weight distribution is as follows:
Wherein described ash content is less than 5wt%;
Preferably, peptide content is more than 82.3wt%, and molecular weight accounts for more than 98.5% less than below 1500Dalton.
Preferably, peptide content is more than 85wt%, and molecular weight accounts for more than 98% less than below 1500Dalton.
Preferably, peptide content is more than 90wt%, and molecular weight accounts for more than 98% less than below 1500Dalton.
Preferably, peptide content is more than 95wt%, and molecular weight accounts for more than 98% less than below 1500Dalton.
Present invention also offers the preparation method that the tower drags down poly- Gly-His-Lys, comprise the steps:
(1) Tara seeds are crushed, crosses 40 mesh with upper screen cloth to obtain Tara powder;
(2) Tara powder and purified water mixs for 1: 10~1: 20 in mass ratio, addition bean powder quality 0.1%~
1% Polyose degradation enzyme, adjusts pH to 5~8,40 DEG C of 1~2h of stirring of constant temperature, after the completion of, centrifugal filtration, filtrate is stand-by;
(3) filter residue in step (2) is mixed with its mass ratio for 1: 10~1: 20 purified water, pH is to 8~10 for regulation,
40 DEG C of 1~2h of extraction of constant temperature, centrifugal filtration after the completion of extraction discards filter residue, and filtrate is stand-by;
(4) filtrate in combining step (2) and (3), regulation pH is 3~5, stands 1~2h, and abandoning supernatant obtains egg
White sediment;
(5) purified water that volume ratio is 1: 5~1: 15 will be added in the albumen precipitation thing in step (4), stir shape
Liquid is redissolved into albumen;
(6) albumen in step (5) is redissolved into liquid and is heated to 40~55 DEG C, add 0.5~2% egg of Tara powder quality
After white enzyme, 4~6h of stirring enzymolysis, adjustment pH is 2~6, boils 10~30min of inactivation, centrifugal filtration, filtrate is standby;
(7) filtrate in step (6) is filtered using aperture for less than 0.5 μm of microfiltration membranes, permeate is again through 100
After~400Dalton nanofiltration membrane treatments, after trapped fluid is concentrated and dried, obtains tower and drag down poly- Gly-His-Lys.
Described preparation method, it is characterised in that:Described method for concentration can for film concentration, be concentrated under reduced pressure or normal pressure is dense
Contracting;Described drying means can be spray drying, vacuum drying, heat drying or freeze-drying.
Described preparation method, it is characterised in that:Described Polyose degradation enzyme is selected from the 1,4 beta-glucanase (enzyme activity of food-grade
Power >=2000U/g) and mannase (enzyme activity >=2000U/g) in a kind of or their mixture, it is preferred to use
1,4 beta-glucanase.
The tower draws the industrialized process for preparing of oligopeptide, it is characterised in that:The biology enzyme is selected from the neutrality of food-grade
Protease (enzyme activity >=300,000 u/g), papain (enzyme activity >=400,000 u/g), the bromelain (u/ of enzyme activity >=300,000
G), alkali protease (enzyme activity >=200,000 u/g), pepsin (enzyme activity >=500,000 u/g), pancreatin (enzyme activity >=3000u/
G) a kind of or their mixture in, it is preferred to use neutral proteinase.
It is highly preferred that the preparation method, which is included in purification procedures, uses 100~400Dalton nanofiltration membrane treatments
The step of.
Present invention also offers a kind of composition, it contains above-mentioned tower and dragged down can connect on poly- Gly-His-Lys, and medicine or food
The auxiliary agent received.
The formulation of the composition be selected from plain piece, thin membrane coated tablet, sugar coated tablet, casing piece, dispersible tablet, capsule, granule,
Oral administration solution or oral administration mixed suspension.
Tower of the present invention drags down poly- Gly-His-Lys, composition, all excessively caused for preparing treatment or prevention free radical
The application of the medicine of symptom, food or health products.Improve the Cardiovascular Toxicity as caused by PM2.5 particulate matters for preparing;Reduction
The particulate matters of PM 2.5 are to macrophage inhibitory action;Strengthen phagocytic function of the macrophage to the particulate matters of PM 2.5;Promote enteron aisle
Application to the secretory medicine, food or health products of the particulate matters of PM 2.5.The oligomeric Gly-His-Lys of described Tara seeds are in
Property protease prepare.
Embodiment
Below by embodiment, the invention will be further described.It should be understood that methods described of the embodiment of the present invention
It is only used for the explanation present invention, rather than limitation of the present invention, to preparation side of the invention under the concept thereof of the present invention
The simple modifications of method belong to the scope of protection of present invention.Unless otherwise instructed, all raw materials for being used in embodiment and
Solvent is commercially available prod.The amount of activity product and positive control medicine of the present invention used in implementing, according to experiment acceptor
Maximum tolerated dose is added.
Comparative example:
The Gly-His-Lys that the A of patent CN 105925648 preparation method is obtained:By Tara seeds (Deposits, Yimen, Yunnan medicinal material market) powder
It is broken, 40 mesh are crossed with upper screen cloth to obtain Tara powder.100kg Tara powders are mixed for 1: 10 in mass ratio with purified water,
0.1% 1,4 beta-glucanase (enzyme activity 3000U/g) of bean powder quality is added, pH to 6,40 DEG C of extraction 2h of constant temperature is adjusted;Extract
After the completion of, centrifugal filtration, filtrate is stand-by;Filter residue is mixed with its mass ratio for 1: 15 purified water again, pH to 9, constant temperature is adjusted
40 DEG C of extraction 2h;Centrifugal filtration after the completion of extraction, discards filter residue, and filtrate is stand-by;Stand-by filtrate more than finally merging, adjusting pH is
3.5,1h is stood, abandoning supernatant adds the purified water that volume ratio is 1: 10 into sediment, is uniformly mixing to obtain albumen redissolution
Liquid.Albumen redissolution liquid is heated to 45 DEG C, 1% neutral proteinase (enzyme activity is 300,000 u/g) of Tara powder quality is added, it is permanent
It is 7 to determine pH, after stirring enzymolysis 4h, boils inactivation 30min, centrifuges, supernatant is protein enzymatic hydrolyzate.Protein enzymatic hydrolyzate is used
Aperture is filtered for 0.5 μm of microfiltration membranes, and permeate is again after 5000Dalton ultrafiltration membrane treatments, and permeate is dense at 50 DEG C
When being reduced to solid contain for 6.5wt%, it is spray-dried, obtains faint yellow tower and draw oligopeptide (lot number is TL-1), yield is
5.9wt%, measures peptide content for 71.32wt%, at least 95.77% peptide molecular weight is distributed in below 1500Dalton.
The Gly-His-Lys obtained by the inventive method:Tara seeds (Deposits, Yimen, Yunnan medicinal material market) are crushed, crosses more than 40 mesh and sieves
Net is so as to obtain Tara powder.100kg Tara powders are mixed for 1: 10 in mass ratio with purified water, bean powder quality is added
0.1% 1,4 beta-glucanase (enzyme activity 3000U/g), adjusts pH to 6,40 DEG C of extraction 2h of constant temperature;After the completion of extraction, centrifuged
Filter, filtrate is stand-by;Filter residue is mixed with its mass ratio for 1: 15 purified water again, pH to 9,40 DEG C of extraction 2h of constant temperature is adjusted;Carry
Centrifugal filtration after the completion of taking, discards filter residue, and filtrate is stand-by;Stand-by filtrate more than finally merging, regulation pH is 3.5, stands 1h, abandons
Supernatant is removed, the purified water that volume ratio is 1: 10 is added into sediment, albumen is uniformly mixing to obtain and redissolves liquid.Albumen is redissolved
Liquid is heated to 45 DEG C, adds 1% neutral proteinase (enzyme activity is 300,000 u/g) of Tara powder quality, constant pH is 7, stirring
Digest after 4h, pH is to 5 for regulation, boil inactivation 30min, centrifuge, supernatant is protein enzymatic hydrolyzate.Protein enzymatic hydrolyzate is used into hole
Footpath is filtered for 0.5 μm of microfiltration membranes, and permeate is again after 100Dalton ultrafiltration membrane treatments, and trapped fluid liquid is dense at 50 DEG C
When being reduced to solid contain for 6.2wt%, it is spray-dried, obtains faint yellow tower and draw oligopeptide (lot number is TL-2), yield is
7.1wt%, measures peptide content for 82.3wt%, at least 98.5% peptide molecular weight is distributed in below 1500Dalton.
BIOLOGICAL ACTIVITY EXAMPLES 1:
1.DPPH radicals scavengings are tested:
The preparation of 1.1 DPPH ethanol solutions:Precision weighs DPPH 4mg, is placed in 100mL brown volumetric flasks, adds
50mL ethanol, ultrasonic 30s, scale is settled to ethanol, is shaken up, stand-by.This product must be now with the current.
The preparation of 1.2 need testing solutions:Precision weighs appropriate tower and dragged down after poly- Gly-His-Lys, plus ethanol dissolving, constant volume, dilution
Into required concentration, you can.
1.3 operating procedure:Accurate absorption 2mL need testing solutions and 2mL DPPH solution are well mixed;It is accurate to draw 2mL
Need testing solution and 2mL ethanol are well mixed;Accurate absorption 2mLDPPH solution and 2mL ethanol are well mixed, and room temperature is placed
30min, determines absorbance, and calculate free radical scavenging activity according to following calculation formula at 515nm wavelength:
IR%=[1- (Ai-Aj)/A0] * 100%;
Wherein, Ai represents the absorbance of solution after solution to be measured and DPPH mixing;
Aj represents the absorbance of solution after solution to be measured and solvent mixing;
A0 represents the absorbance of solution after DPPH and solvent mixing.
2. ABTS+Radicals scavenging is tested:
The preparation of 2.1 PBSs:Weigh sodium chloride 8g, potassium chloride 0.2g, potassium dihydrogen phosphate 0.24g, 12 hydrations
Disodium hydrogen phosphate 3.62g, is placed in 1000mL beakers, and adding 800mL distilled water , Jiao Ban dissolves it, with hydrochloric acid or hydroxide
Sodium adjusts pH to 7.4, is transferred in 1000mL volumetric flasks, plus distilled water diluting is to scale, shakes up, stand-by.
2.2 ABTS+The preparation of stock solution:Precision weighs ABTS+78mg or so, is placed in 20mL brown volumetric flasks, plus
Enter 15mL distilled water, ultrasonic 5min is settled to scale with distilled water, shaken up.Precision weighs potassium peroxydisulfate 76mg or so, is placed in
In 2mL brown volumetric flasks, 1mL distilled water is added, ultrasound dissolves it, scale is settled to distilled water, shakes up.It is accurate to draw
352 μ L potassium persulfate solutions are added into ABTS solution, are shaken up, are stood overnight.
2.3 ABTS+The preparation of working solution:It is accurate to draw stock solution 1mL, 65mL or so PBS is added, is shaken
It is even.
The preparation of 2.4 need testing solutions:Precision weighs appropriate tower and drawn after oligopeptide, plus PBS dissolving, and constant volume is dilute
It is interpreted into required concentration, you can.
2.5 operating procedure:Accurate absorption 0.5mL need testing solutions and 5mL ABTS working solutions are well mixed;It is accurate to inhale
Take 0.5mL need testing solutions and 5mL PBSs well mixed;It is accurate to draw 5mL ABTS working solutions and 0.5mL PBS
Buffer solution is well mixed, and determines absorbance at 734nm immediately, and calculate free radical scavenging activity according to below equation:
IR%=[1- (Ai-Aj)/A0] * 100%;
Wherein, Ai represents the absorbance of solution after solution to be measured and ABTS mixing;
Aj represents the absorbance of solution after solution to be measured and solvent mixing;
A0 represents the absorbance of solution after ABTS and solvent mixing.
3.SRSA ultra-oxygen anion free radicals remove experiment:
The preparation of 3.1 NBT solution:Precision weighs NBT (NBT) 24.5mg, is placed in 100mL browns appearance
In measuring bottle, 50mL distilled water is added, ultrasonic 30s is settled to scale with distilled water, shaken up, stand-by.
The preparation of 3.2 NADH solution:Precision weighs NADH reduced Coenzyme I (NADH)
33.2mg, is placed in 100mL brown volumetric flasks, adds 50mL distilled water, and ultrasonic 30s is settled to scale with distilled water, shaken up,
It is stand-by.
The preparation of 3.3 PMS solution:Precision weighs phenazine methosulfate (PMS) 4.59mg, is placed in 250mL brown volumetric flasks
In, 150mL distilled water is added, ultrasonic 30s is settled to scale with distilled water, shaken up, stand-by.
The preparation of 3.4 Tris-HCl cushioning liquid:Precision weighs trishydroxymethylaminomethane (Tris) 3.025g, is placed in
In 500mL beakers, 200mL distilled water is added, stirring dissolves it, adjust pH to 8.0 with 1M HCl, be transferred to 250mL capacity
In bottle, scale is settled to distilled water, is shaken up, it is stand-by.In use, taking the above-mentioned solution of 16mL to be placed in 100mL volumetric flasks, plus steam
Distilled water is diluted to scale.
The preparation of 3.3 need testing solutions:Precision weighs appropriate tower and drawn after oligopeptide, plus Tris-HCl buffer solutions, fixed
Hold, be diluted to required concentration, you can.
The detection of 3.4 light absorption values and the calculating of free radical scavenging activity:It is accurate to draw 1mL NADH solution, 1mL NBT solution and
3mL need testing solutions, control plus 3mLTris-HCl cushioning liquid, are well mixed respectively, respectively add 1mL PMS solution to mix, room temperature
5min is placed, absorbance is determined at 558nm, free radical scavenging activity calculation formula is as follows:
IR% (SRSA)=(1-Ai/A0) * 100%
Wherein, Ai represents the absorbance of solution after solution to be measured and detection reagent mixing;
A0 represents the absorbance of solution after blank solution and detection reagent mixing.
Preparing the tower of not be the same as Example respectively, to drag down poly- peptide product (lot number is TL-1 and TL-2) concentration be 1mg/mL, to tie up
Raw element C is positive control (concentration is 0.1mg/mL), and test result is as shown in table 1:
The tower of table 1 drags down poly- Gly-His-Lys antioxidation activity
As shown in Table 1, the tower prepared by two methods drags down poly- Gly-His-Lys has stronger scavenging action to ABTS free radicals,
Clearance rate is shown as medium more than 90% to the clearance rate of DPPH free radicals and superoxide anion (SRSA) more than 50%
Intensity scavenging action.And removing of the oligopeptide (TL-2) to three kinds of free radicals is drawn by the tower prepared by this patent disclosed method
Effect is preferable, thus it is speculated that reason is higher peptide content.It can be seen that the tower prepared by the inventive method of use this patent drags down poly- Gly-His-Lys
It is equally applicable to prepare medicine, food or the health food for treating or preventing the excessive caused symptom of free radical.
Claims (10)
1. a kind of tower draws oligopeptide, it is characterised in that:Using GB/T 22492-2008 appendix As and the detection method of Appendix B, survey
Peptide content is obtained in more than 80wt%, molecular weight accounts for more than 98% less than 1500 below Dalton, and its molecular weight distribution is as follows:
Wherein described ash content is less than 5wt%;
Preferably, peptide content is more than 82.3wt%, and molecular weight accounts for more than 98.5% less than 1500 below Dalton.
2. tower described in claim 1 draws the industrialized process for preparing of oligopeptide, it is characterised in that comprise the steps:It is pure separating
Change and 100~400 Dalton nanofiltration membrane treatments are used in step.
3. tower draws the industrialized process for preparing of oligopeptide according to claim 2, it is characterised in that comprise the steps:
(1) Tara seeds are crushed, crosses 40 mesh with upper screen cloth to obtain Tara powder;
(2) Tara powder and purified water mixs for 1: 10~1: 20 in mass ratio, the 0.1%~1% of addition bean powder quality
Polyose degradation enzyme, adjusts pH to 5~8,40 DEG C of 1~2h of stirring of constant temperature, after the completion of, centrifugal filtration, filtrate is stand-by;
(3) filter residue in step (2) is mixed with its mass ratio for 1: 10~1: 20 purified water, adjusts pH to 8~10, constant temperature
40 DEG C of 1~2h of extraction, centrifugal filtration after the completion of extraction discards filter residue, and filtrate is stand-by;
(4) filtrate in combining step (2) and (3), regulation pH is 3~5, stands 1~2h, and abandoning supernatant obtains albumen and sunk
Starch;
(5) purified water that volume ratio is 1: 5~1: 15 will be added in the albumen precipitation thing in step (4), stirs to form egg
It is white to redissolve liquid;
(6) albumen in step (5) is redissolved into liquid and is heated to 40~55 DEG C, add 0.5~2% albumen of Tara powder quality
After enzyme, 4~6h of stirring enzymolysis, adjustment pH is 2~6, boils 10~30min of inactivation, centrifugal filtration, filtrate is standby;
(7) filtrate in step (6) is filtered using aperture for less than 0.5 μm of microfiltration membranes, permeate again through 100~
After 400 Dalton nanofiltration membrane treatments, after trapped fluid is concentrated and dried, obtains tower and drag down poly- Gly-His-Lys.
4. preparation method according to claim 3, it is characterised in that:Described method for concentration can be film concentration, decompression
Concentration or normal pressure concentration;Described drying means can be spray drying, vacuum drying, heat drying or freeze-drying.
5. preparation method according to claim 3, it is characterised in that:Described Polyose degradation enzyme is selected from β-Portugal of food-grade
A kind of or their mixture in dextranase (enzyme activity >=2000U/g) and mannase (enzyme activity >=2000U/g),
1,4 beta-glucanase is preferably used.
6. tower draws the industrialized process for preparing of oligopeptide according to claim 3, it is characterised in that:The biology enzyme is selected from food
The neutral proteinase (enzyme activity >=300,000 u/g) of grade, papain (enzyme activity >=400,000 u/g), bromelain (enzyme activity
The u/g of power >=300,000), alkali protease (enzyme activity >=200,000 u/g), pepsin (enzyme activity >=500,000 u/g), pancreatin (enzyme activity
Power >=3000u/g) in a kind of or their mixture, it is preferred to use neutral proteinase.
7. a kind of tower draws oligopeptide, it is characterised in that:Using GB/T 22492-2008 appendix As and the detection method of Appendix B, survey
Peptide content is obtained in more than 80wt%, molecular weight accounts for more than 98% less than 1500 below Dalton, and its molecular weight distribution is as follows:
Wherein described ash content is less than 5wt%;
Preferably, peptide content is more than 82.3wt%, and molecular weight accounts for more than 98.5% less than 1500 below Dalton.
The tower draw oligopeptide to be prepared by any described methods of claim 2-6.
8. a kind of composition, it is characterised in that:Being dragged down containing the tower described in claim 1 can on poly- Gly-His-Lys, and medicine or food
The auxiliary agent of receiving.
9. composition according to claim 8, it is characterised in that:Its formulation be selected from plain piece, thin membrane coated tablet, sugar coated tablet,
Casing piece, dispersible tablet, capsule, granule, oral administration solution or oral administration mixed suspension.
10. the tower described in claim 1 drag down poly- Gly-His-Lys be used for prepare treat or prevent the medicine of the excessive caused symptom of free radical
The application of thing, food or health products;Improve the Cardiovascular Toxicity as caused by the particulate matters of PM 2.5 for preparing;Reduce PM 2.5
Grain thing is to macrophage inhibitory action;Strengthen phagocytic function of the macrophage to the particulate matters of PM 2.5;Promote enteron aisle to PM 2.5
The application of the secretory medicine of particulate matter, food or health products.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710588063.7A CN107287270A (en) | 2017-07-18 | 2017-07-18 | A kind of tower draws oligopeptide and its industrialized process for preparing and purposes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710588063.7A CN107287270A (en) | 2017-07-18 | 2017-07-18 | A kind of tower draws oligopeptide and its industrialized process for preparing and purposes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107287270A true CN107287270A (en) | 2017-10-24 |
Family
ID=60101813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710588063.7A Pending CN107287270A (en) | 2017-07-18 | 2017-07-18 | A kind of tower draws oligopeptide and its industrialized process for preparing and purposes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107287270A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559826A (en) * | 2012-02-15 | 2012-07-11 | 胡如桂 | Method for preparing collagen oligopeptide |
WO2012118780A2 (en) * | 2011-02-28 | 2012-09-07 | Polytechnic Institute Of New York University | Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties |
CN103667408B (en) * | 2013-11-21 | 2015-09-23 | 中国农业科学院农产品加工研究所 | A kind of method utilizing wheat protein to prepare intestine nutritive peptide |
CN105154506A (en) * | 2015-09-21 | 2015-12-16 | 常熟理工学院 | Food-grade low-salinity ocean fish oligopeptide powder and application thereof |
CN105925648A (en) * | 2016-05-17 | 2016-09-07 | 杏辉天力(杭州)药业有限公司 | Tara albumen powder and polypeptide powder and production method thereof |
-
2017
- 2017-07-18 CN CN201710588063.7A patent/CN107287270A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012118780A2 (en) * | 2011-02-28 | 2012-09-07 | Polytechnic Institute Of New York University | Preparation of peptide mixtures by protease catalysis designed to provide useful biological and physical properties |
CN102559826A (en) * | 2012-02-15 | 2012-07-11 | 胡如桂 | Method for preparing collagen oligopeptide |
CN103667408B (en) * | 2013-11-21 | 2015-09-23 | 中国农业科学院农产品加工研究所 | A kind of method utilizing wheat protein to prepare intestine nutritive peptide |
CN105154506A (en) * | 2015-09-21 | 2015-12-16 | 常熟理工学院 | Food-grade low-salinity ocean fish oligopeptide powder and application thereof |
CN105925648A (en) * | 2016-05-17 | 2016-09-07 | 杏辉天力(杭州)药业有限公司 | Tara albumen powder and polypeptide powder and production method thereof |
Non-Patent Citations (4)
Title |
---|
TSURU, T: "PEPTIDE AND AMINO-ACID SEPARATION WITH NANOFILTRATION MEMBRANES", 《SEPARATION SCIENCE AND TECHNOLOGY》 * |
何东平等: "《油脂工厂设计手册 上》", 31 August 2012 * |
姚红娟等: "膜分离技术在低分子量生物产品分离纯化中的应用", 《化工进展》 * |
曾庆祝等: "《食品质量与安全检测第1版》", 30 September 2015 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9635875B2 (en) | Production of pulse protein products with reduced astringency | |
CN102387714B (en) | Preparation of soy protein product using water extraction ( | |
Lindeboom | Studies on the characterization, biosynthesis and isolation of starch and protein from quinoa (Chenopodium quinoa Willd.) | |
JP2542462B2 (en) | Sugar composition containing soluble fiber | |
CN102340995A (en) | Granulated powder containing vegetable proteins and fibres, method for producing same, and use thereof | |
CN104152521B (en) | Peony pollen polypeptide and preparation method and application | |
CN103079410A (en) | Production of soluble protein solutions from pulses | |
CN102340996A (en) | Granulated powder containing vegetable proteins and maltodextrins, method for producing same, and uses thereof | |
CN107691963A (en) | Extracted using calcium chloride and prepare soy protein isolate (" S703 ") | |
CN113747801A (en) | Vicia faba protein composition | |
US20200329737A1 (en) | Potato protein based fibrous structures and food items comprising the same | |
CN105925648B (en) | A kind of tower draws albumen powder and polypeptide powder and its production method | |
CN106962923A (en) | It is a kind of for it is physically weak, after being ill, the ocean dietary composition taken good care of of operation and preparation method thereof | |
CN107383159A (en) | A kind of chick-pea oligopeptide and its industrialized process for preparing and purposes | |
CN103841835A (en) | Preparation of soy protein isolate using calcium chloride extraction (S703 CIP) | |
Nani et al. | Circular economy for food industry waste: Development and characterization of spray-dried acid whey encapsulated in millet matrix | |
US11134705B2 (en) | pH adjusted pulse protein product | |
CN107287270A (en) | A kind of tower draws oligopeptide and its industrialized process for preparing and purposes | |
CN109287843A (en) | A kind of rice protein and preparation method thereof | |
CN108882724A (en) | The preparation of non-soybean oilseeds protein product (" * 810 ") | |
CN107041531A (en) | A kind of full potato class Yoghourt cake of the gluten-free type albumen containing mashed potatoes and preparation method thereof | |
CN110089755A (en) | A kind of gel woody compound starch and preparation method | |
CN107446975B (en) | High-purity walnut oligopeptide, and industrial preparation method and application thereof | |
CN107173408A (en) | Fine Yoghourt cake of a kind of height rich in potato residues and preparation method thereof | |
JP7357013B2 (en) | Process of producing non-vital wheat protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171024 |
|
RJ01 | Rejection of invention patent application after publication |